INGREZZA® (valbenazine) capsules is an FDA-approved treatment for adults with the uncontrollable movements of tardive dyskinesia (TD).

Are your uncontrollable body movements always in the spotlight?

Shift the focus more on you with fewer uncontrollable body movements

The only once-daily treatment specifically designed for TD

Not an actual patient

Shift the focus more on you with fewer uncontrollable body movements

The only once-daily treatment specifically designed for TD

INGREZZA is proven to reduce mild, moderate, and severe body movements from tardive dyskinesia (TD).

In a clinical study, 7 out of 10 people taking INGREZZA® (valbenazine) capsules 80 mg saw improvements in TD movements at 6 weeks—and many started to see results as soon as 2 weeks.

  • Patients had at least a 1-point reduction on an uncontrollable movement severity scale at 6 weeks vs before treatment.
  • This post-clinical study evaluation included 70 patients taking INGREZZA 80 mg, measuring uncontrollable movements before starting treatment and at 6 weeks of treatment.

Discover what causes TD
and how it's treated.

See how INGREZZA can
help TD movements

See how INGREZZA
made a difference
in people's lives.

Allison was compensated by Neurocrine Biosciences, Inc. to share her story

You could pay as little as $0 on your INGREZZA prescription.*

The only once‑daily
treatment for
adults with TD.

*Not available for patients with government-funded prescription insurance. Additional terms and conditions apply.

Ready to talk about tardive dyskinesia (TD) treatment? Find a specialist.

Whether your uncontrollable body movements are mild, moderate, or severe, connecting with a psychiatry or neurology healthcare provider who may be able to help you diagnose and treat TD is important.

Enter your ZIP code to find a specialist near you and ask about INGREZZA.a

Go
Not an
actual patient
  • Neurocrine Biosciences, Inc. is providing this service to help patients find healthcare professionals in their area who have experience with tardive dyskinesia (TD).

No fees have been received by or paid to healthcare professionals for inclusion in this locator directory. Inclusion of a healthcare professional in this directory does not represent an endorsement by or a recommendation from Neurocrine Biosciences, nor does it imply that the healthcare professional on the list will determine that a Neurocrine Biosciences product is right for you. Neurocrine Biosciences makes no warranty as to the credentials, skill, or outcomes of the listed professional.

Information posted to this site is provided for educational and informational purposes only. You are ultimately responsible for the selection of a healthcare professional and it is an important decision that you should consider carefully. This healthcare professional locator tool is just one source of information available to you.

Receive emails about INGREZZA, what you can expect while taking it, and what patient support programs may be available.

Sign up for info
Not an actual patient

Indication and Important Safety Information

Do not take INGREZZA if you are allergic to valbenazine, or any of the ingredients in INGREZZA.

Expand
Collapse

Important Information

Approved Use

INGREZZA® (valbenazine) capsules is a prescription medicine used to treat adults with movements in the face, tongue, or other body parts that cannot be controlled (tardive dyskinesia).

It is not known if INGREZZA is safe and effective in children.

IMPORTANT SAFETY INFORMATION

Do not take INGREZZA if you:

  • are allergic to valbenazine, or any of the ingredients in INGREZZA.

INGREZZA may cause serious side effects, including:

  • Sleepiness (somnolence). Do not drive, operate heavy machinery, or do other dangerous activities until you know how INGREZZA affects you.
  • Heart rhythm problems (QT prolongation). INGREZZA may cause a heart problem known as QT prolongation.
  • Symptoms of QT prolongation may include:
    • fast, slow, or irregular heartbeat
    • shortness of breath
    • dizziness or fainting
  • Tell your healthcare provider right away if you have a change in your heartbeat (a fast or irregular heartbeat), or if you faint.
  • Abnormal movements (Parkinson-like). Symptoms include: shaking, body stiffness, trouble moving or walking, or keeping your balance.

Before taking INGREZZA, tell your healthcare provider about all of your medical conditions including if you: have liver or heart problems, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

The most common side effect of INGREZZA is sleepiness (somnolence). Other side effects include changes in balance (balance problems, dizziness) or an increased risk of falls, headache, feelings of restlessness, dry mouth, constipation, and blurred vision.

These are not all of the possible side effects of INGREZZA. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch at www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see accompanying INGREZZA full Product Information

You are now leaving Ingrezza.com

Neurocrine Biosciences, Inc. is not responsible for the content of linked third-party websites. Please be aware that the privacy policies and terms of use on these sites are different from Neurocrine Biosciences, Inc. policies.

Stay Here Leave Site